Barry A. Boilson
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Daratumumab in HLA Desensitization Prior to Transplantation (NCT05300451) | Barry A. Boilson | 2022-03-31 |
Track Barry A. Boilson automatically
Every clearance here is in the API, with alerts when new ones post.